<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,d09GRk9UVE8AABQIAAoAAAAAGsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABDRkYgAAAEHAAADtkAABObNgl01EZGVE0AABL4AAAAHAAAABxJy/H0T1MvMgAAAVQAAABRAAAAYESbB3VjbWFwAAAC2AAAAS0AAAIe+OcoKWhlYWQAAAD0AAAANgAAADbXru5raGhlYQAAASwAAAAfAAAAJAaqAoRobXR4AAATFAAAAPMAAAEuhpQLWm1heHAAAAFMAAAABgAAAAYATFAAbmFtZQAAAagAAAEtAAACKPg6esZwb3N0AAAECAAAABMAAAAg/4YAMgABAAAAABAAa/F+mV8PPPUACwPoAAAAAJ4LficAAAAA16ccjf/Z/ycDBQOrAAAACAACAAAAAAAAeNpjYGRgYD75Xw5IOv6/+f8mMysDUAQFeAMAlQIGMwAAAFAAAEwAAHjaY2BmvM74hYGVgYGpi2k3AwNDD4RmvM9gyMgE5DOwMUBAAwODfgADgxeUy6BlZKgFpBR+MzGf/C/HkMJ8kuERTI5JgukMgwIQMgIA0JMOTwAAAHjalZA9TsNAEIXf5gfbEooQokCIwqIkShSLhtZJikQpksbpI3sVrWLWiq0kd+AIlJyBFsE5uACCA1BQ8bxMS4FHM/vt29l5KwM4wxcUfr8TXAkrXOJOuAEPD8JN+HgSbjFfhNs4xpvwEfND2GN8C/vw1KlwQL7mNNUKuAvd5JoVbnEj3EAH98JNvu1RuPZ9Fm7jHK/Cte+7sMe7n8I+OqohHJAvMEcJgzXTYoWc/jk5hea+rpiXZm3sKg9zk2qbUoldLDDDBF0kbDTYs7VEhR5GKKhkbkDFmmFIJeeKOI4Xs0k3sWavy6o3KmymbaWzYZHztB60YRY4sCKxG1scCDtnsOWqMcWYgjXbnZ6O3d9birFxtiEG6CNiYEkLU9hw0I8i1/nX/H/qP+2LUy8AAAB42mNgYGBmgGAZBkYgycAoAeQxgvksDH+AtBWDApAlBSQ1GYyAvDCGSIYqhi0MBxkeMrxkeMvwkeEzwy9GQ8YKxklMdxRkFdQUDBRcFNYoKikJPZD6zfT/P9AMBQYNBh2gXkeGCIZEnHplUPRK/mb8////w/+3/t/4f/H/6f+n/h/+3/W/7n/8/4j/of+D/gf+9/4v+q/jX97f7Ac692/dv3B/z/2Qe/fuvmNgYPWE+IVkwAYmGRlYgQQbA0FDYPJMwPBjYWVj5+DkgopwQygeXj5+AUEhYRFRMXEJSSlpGVk5eQVFBiVlqDIVVTV1DU0tbR1dPX0DQyNjE1MzcwtLK2sbW2RrHCCUIxA7AbGzC4jniuoUO+I86OGJYHt5Qxn2KErcGNxhTACW01ftAAAAeNpjYGYAg//NDEYMWAAAKEQBuAB42o1YDVgVZfZ/r3OZGT4ciGluZjjXCwIifoQouekqYCiKKIqoYGIliuIHmh+oWSigcnm5fuJHkAmCn6GWUmKZZYXYpmmbm6TVFq25+7T6l7I9w57rs/8zXDDdZ7dn74WHe2fe97znd87vd84ZLMxqZRZ6MUsnZmGRxmPMCLIY3ToZumA8bM3C+a0v/3OYVxCb4x/EWECQhT0UxKKDAp8KZFZzg1fb2/F436iouLi4lKTEyLQFc5bNfH5xn+G5C7JmLlg8Mys+d14Wo5eFeTMf1pkpzJ8FsIdYIFPZYyyYhbAeLJSFsXDWk0WwXiyS9WZ9WF/Wjz3Oolh/Fs0GsIEshj3BfseeZPFsOHuKJbARbCRLZKPYaJbExrBkNpaNYylsPJvAUtlElsYmsclsCktnGWwqe5G9xs6xi+xzdoU1sW/YZpbP5rA8Np8tYGNMFFYmsWFsOdvIqtlJ9kfLo5Z4i8vyhuVyp2GdXu50VRCFPoJTOClcslqtA60p1i3WRq9ArzSvs2IfsUZsEP8lhUmZUoncSc6WX/P2947xTva+4RPsE+eT53PUp9G3l+8c3wLf636j/Ao7S51HdnZ1Ptb5lhKqJCsvKZuVWn/JP8Q/2j/bf7n/Mf+z/l8GCAG9A1YHHHBvU+gHy7HzP5mlFvwEsLeu12aEjsKRHCM4hp/F6Lexu3xVXAzqc9CdwwgO/Y9C5AFQZAWz2vbBQ20bsbN2vOUCjOQQwSE8BaKfhu7yELEa1TrsznEEx/7ZGLkAzY0nesEKSw3ECjW9tB/5FViBj3AvBRMht8VyApzCCfiTFgrOFomWcuhiOU0nnIYuGnYBP+hCV1e3zsqzzIW/CX+M1KCg9Wwox8K7Z72UEQUtRlmLZTc4QAGHAM+3TtYwdn5/3I25L6MDUiDlZbqXC7vn/wVj7aHWxtLncC5mr8tMTV1XD9kwt7Su0a5gWOWy1rF5FhgMkcIpY7pWV1W39+hB2X0YIlvHYlcp++mMnPRcWYnlwIy1LZY9ZFSkA42hNmD4qnTlz5BkxiqKwyODTmFnjhqPH74NbTI4xPoNHzQc35kzW+cDps3BhXhSRv92pLC2A63h6kDr9rain/lZVG5WLoMBIBiT8yxbjRsCRNm6+xgMqjXswS/BeRcF8R8cBHiWfseAEHgeIiERwtEOkeodmAeXtO/FK9VZSWHDS+banxCNYqtq/FU8fTRrUsK0pTn2MBFk9zBNLfoEordCkp3fyr3UvVx2SWr91xV1jfwbGfr2rkVJx8q7s0TlQj6B3wcs8EPoA/2hJ8U3Qv0rNORr4Gj6GNLsGCE6J2yISuByzOprkAzJ2699a1cX1r+SHWmHnuJm6Jf8LfblMro4jsZUO47nOAZcuvILgTCKQbBcIABJ0EeA+QZoX4p3OHrjozhqxYh+9ngRI1HQoESE7SthCyFeOgu6YIYdN4lKuRmFbPodQUb+QEk0ZtpAwI10bQn9XULX14Pg1u/OkpQVFNSLtDSZljbSUsi20fccWpZD12i529dc1px/B+JpWSkwiwk4ybR63CjWyiCy3zfYk2DwAkwmIPsOBMMWeyP/qaJuq2x0whdR+BoHSEsKF659nssDlx6HZaaU1L/Zr/HtKSWJcltevyDbb+ZZLhLiONOLXCNBgzcx8u4suvIFxOEXxL1ZhPlNk//ET1KAiQxybOZl08U0SkirmGcph74QYN462TpLc5+T5i2eN2fIzu8adOwr4qCyaMj+R8sZCNSN05Lyg8fSGXP5DCNKc8LHnjMN0SVCnFuEoRwzjWDIhCZ8kghWyMHPuJVn+cTEn2wDP1xm3PKcD5c9xhoh3HgCwsmgzTjjkqCL+wz04GCnL5zT53DOyeV8jn7ufCdHLyMf13N+d5aXAn09Fj4hPW0zBfyszaghC+nuGpjatstBFopp00SjGJ/xbPp7Ow/b0jLRZEvDj9qvjPt2+2BKS/LqwTF2ZFZwcZLGeEjlMBpd7cxrJ55duUqJeJsS8RxxgQCS2MjaXOLeFfFiRXrK1HkZmaQbjHRHaHT3bbCKkFANtq+hS9qfUbdjjahAryJgYcTfHe3KII/U5cbPIGhjxFU8a/nStbLT5dX47v6LHPrJDzqiq5tw4370hsW6mriPH96yl8swR1Tr8YPbbZASf4Vkx0TCpCuXyOf3PphIXk8jyRODIRzC1VOQTW5/Kr5zYNGIaSvHjbMniihYj5HCC+MH2vnT6zN2T5dJhC8eLIYgflJWv+Jgi9ias5HkfrPi6CV+Qwb/URd66PiayQZRqetQez1EYjDh6kmFpQdhu2xshXSNQx5+lM+hm/zugX2ndHXKubKJaXYIF7dBZPwFDKcA87QoSraslnGcCx8VcqqGGc/nTNHVykHFDZfsGCkW4kNHsBOMI9ASdKuCcXblxUqiF/hZSHuRwmbiM/rBEPct4uctGAJ+knKznfQm8PEmJ3uYpC+RBs+fPmrizCN/0Y0SyleZhEHXBsKTMOYcFWqmG2WS8paHa5uMtwRIskECh1QiGLW9QHcVMcxqVGEUEf5Nz7INxkkBJhiKhuPcCjxuFhgX1QgXDOOYZFgoM620PAzX9IA1GEv72s3DFFNaU2zk3gYRMo15VPFQwgZk0IC/4zDePc9LWbSmeWgTDL4KXlcD60DHQNChE/1VQVVXwhko1tQShw/oLdqNJU04Uldj0vi0grmLc5Ysz+JjZdDF4xtfP3V687xn9CxJPYiPuFAr4jiYRx+Nv8nP8bqag+/J1B7UuM2JQL22+ND61/ghWVnXdu7PzTAjj7jaFbuS7rxBV/fBliZtasH7oN4u+azhXElCmB3VgkmUq6cwY6imJkJXUT30oUvam3Fs5RlKV9g6iPm5ZSNEYbBdHTCFz1614BnZCbvQISprrsPN69TXHfCw2SIz4EsNusQ1oA3H5qEP6ti/GgUYDV3+dBa66bRj1LIZ0ye/VAt972x6v/HEq8/H6u0B8jh6koLjDQ5ytqtaC8VN2pR2R881dDg6VVdXATlqFgzc5ZQWvDW7fApV6OCNGBVqV0tC1mEMhOln+LFX9p6SXaIanyop+eRor6vg20y+BoNmlp+x8LH2VsmV8586EzJ0cAzRgn0ULCJKxjSD7QbVX1qzt3WOFuKj5OKkq0Og1+lmaG4a2hx4grJnI0eFdkeXMkK4RlP7MOhb9vr7720ag0L3IoroyC0/vm1XA1ZDIFRqau/VKU4p7+1nqtLJ23AneS+gWER662dXaXTkx3dXHpNdvcQpK2l+WMpf2FKwU1ZTWcGO4l28UkZd3ID+1xfeoYxMcoJ+xG7skRRyN9YMHNVHxy9mBlJsRoT0WcrxRH0Sn/lCbiYlqhIdJHMH3Bbrtx6pr986O1PH255GY7jyyDeBOhOBnUlzSQ8fdJDGQikUezH1hnH71/sX6bb7Yyl7WfELen+pwlleUsHl7+qP37Eb70g0H8w3d+312FyTZ3nfNDnJBvupxD+C+yGaYzTUQggsNQuGinOcnBvxZs0363xH12s7iBwwHW41285ME6EZ9HoToE4YHw5Sv4Kx5gzlcLv+HRboEpXH29L9lxwdERnPZ+TlTF9yfEZ1Ou+Ijqh0HOCJoNoE6f/NtmlIHfRAcO9XgM1EvOGaFuYTZQ33MfUHP3sM/yq+8/fEZ1d7d+hP9+gPM4zYNuCwyyUdeObIqtOU6uD1ENVCsvt5E8RgmJ7Gs1YuyqBz1ZQPJWVpxxHv3CebJihpl41dHdShHN2jHDCPIJ2TwutSndKiU1mvpBEZwzZhTEjoeowCUnjxaX6k/MBbsgt30UCrYFcK0KMQuOZeFVEPfGhSwYzPfom/6/ocAgplNQUCpQl86spF403vHj8vKcPXNA+AWMiAfkOuBu4H/aan+Kk5+yFGK0TH1/PAn4M3//wC/15Wu3ICWLqeX+OHX9l9iMvqw+V8h7OsQFZ7byvYuIzPNivhVrAMOBnJH+fIcjhaZLWE40Aorebd+ZzFK3J5Ll+1tbBCVhOLKkqqSvfQ40jxuuvwXbMpD6HEiNE+wk/EeRVPgqIf5rs3vOqSm6UiZwEv4PK00po37LDncnM8hBCdx/DBE8yJyKxNRmxeBzuWw4c2CBOLa52Hea1sRJCIf5IyC3MyMwtr63X4iXhDHNmZcHbGp/r7/I2K/fVUgZQRbaqguT5WgGAb9DPnJRfqPM7t7+RPGf4YQkfBLs+q7a3FAnSzQS/eAjdd/Ae8CT2p99KGx/gwd4CT9zcCMIz3Mj+OoI/dae8Sz9ZNxhIBCiBB+x4TTMGFQgU8ButIZDHYJw76YH8yhEUYQak1t40wN5UZQ4UbmKqZp0xuHYNBfBiCkw8HINPQzb2Z1BnAr8PF/4u6HrgHflRfh3+ZCvkuClJFzMCLPBx+5Pw6jWxeaiwNKhdpw2jjCoRQDVgqQAjJuaePcvM/PNFsB8O8taitC97fA3+jA/7X/vdA98PkVtk0nf+fyvxFY7V5D0e3l7xRHg9/W/gPyp6eHjdrEbTnnt43ti40jRT+LwR5kB4ZrdFt7njq8f21WMEC40sItGTBLwJspuddOjHBqIJ0yzvw+zL4vWDYyfVIHo/p0JV7YQgNa/e+PbjyHaOKHscvQzrSLQjB9F+/tdEzpvkXmngEkPvdCKTWd4u4/oORcn9HUC/jsA3aytIXSldyGoJ2DC3FUDlpwB/cMRSfmAvNo0TV75zET++o+mi93G4TbM0D7tn7qr2dqjUHm+8VeKP4YWOblr+jddYOXLENkspE2LMTHiu/ay2XuJ8PCD5N28rLyvz8wOFb6qcEsWiV+Zj/dunKerPprIiVsjJ2gJ1ln1n86mimf44fxwEm96fQfDCV49PUXXwn7kTroGlrTxzV+fX31n62QfalaroM/HECFb8HBhX7Bf7urtpDhw/tqnd9IGOI+OyaqenJzuuNuu9vID8ntsP29dBH9CVbDhAk33ujTuOmScHY96WcyXZfGF1No0N/0PPAB8f+2/m+URhynhOQEC/f4vmrqKa9wJduX0zvheULeDKfPbwoTT4rbqzctqeGV/LqwpqXal7at2Y/r+XVVRVVr1RtO7jpoOz7/5HQe9AAAAAAAAABAAAAANQZVz8AAAAAngt+JwAAAADXpxyNeNo9kL1KA1EQhb8zSzT+oRIXkRRiqVnRIAlbLJhosBHB0sLKlAo+gLXPYOF7CGLewM4ujdiIoIWCaxEU1rkxeOFy5pw5M3Pnwuh8s6I6GY8s6YDEcUtx8aQeCzqnrhumg2ZdynZG23ZJ7ZQdm2Nb72R25LxLR7Hze2btmKYGtKK2565p2YnnDx2vHPdcW6OmT8a8JrOEktWIHMf1wqp+SJWTeLyuL8d50LP7c9djOnywbFUaIbYH9+Qjf6h7Y0MXjrdUNVMU/obUdyhHk0zplZLHE7pkUfs0wi7DeWGG8/8+g785qhR93bE5vL3wSb/moztGAA==); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7953 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">438</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7953 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.9449 2.1669 2.3889 2.6669 2.8889 3.3329" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Delirio.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.7779 1.9999 2.3889 2.8329 3.2219 3.4439 3.8329" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Psicosis.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 734.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.4449 1.8889 2.1669 2.6109 2.8329 3.2769 3.7209" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Cefalea.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 712.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 712.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 1.1169 1.5609 1.9499 2.3389 2.7829 3.0049 3.4489 3.8929 4.2819 4.7259 5.1699 5.6139 5.8359 6.2799 6.5579 6.7799 7.1689 7.6129 8.0019" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Musculoesqueléticos:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 701.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.9449 2.3889 2.6109 2.8329 3.0549 3.4989 3.9429 4.3869 4.6088 5.2758 5.7198 6.1088 6.4978 6.9418 7.1638 7.6078 7.8158" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Debilidad muscular.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 690.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.8899 2.1679 2.6119 3.0559 3.4999 3.9439 4.2219 4.6659 5.0549 5.2769 5.6659" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Osteoporosis.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 679.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.945 2.167 2.611 2.889 3.111 3.555 3.999 4.221 4.665 5.054 5.498 5.942 6.164 6.608 7.052" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Dolor de espalda.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 657.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.5 1 1.5 2 2.278 2.778 3.278 3.722 3.944 4.388 4.61 5.332 5.832 6.332 6.61 7.11 7.554 7.776 8.276 8.776 8.998 9.498 9.776 10.276 10.776 11.276 11.776 12.22 12.498 12.776 13.276" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Técnicas y medios de diagnóstico</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 635.8375) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 2.116 2.56 3.004 3.282 3.56 4.004 4.393 4.615 5.059 5.503 5.947 6.336 6.558 6.947 7.391 7.669 7.891 8.28 8.724 9.113 9.335 9.779 10.168 10.557 11.001 11.39 11.612 12.001 12.445 12.834 13.056 13.5 13.944 14.166 14.555 14.999 15.277 15.555 15.777 16.166 16.61 16.832" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Concentraciones séricas excesivas de cortisol.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 2.006 2.45 2.894 3.172 3.616 3.838 4.282 4.726 4.948 5.17 5.614 5.836 6.392 6.892 7.336 7.892 8.114 8.558 8.78 9.224 9.613 10.28 10.724 11.002 11.224 11.613 12.057 12.279 12.723 13.167 13.389 13.833 14.277 14.555 14.944 15.388 15.832 16.276 16.665 16.887 17.276 17.72 18.164 18.386 18.83 19.274 19.718 20.162 20.384 20.828 21.217 21.439 21.883 22.272 22.494 22.938 23.16 23.604 24.048 24.27 24.492 24.881 25.325 25.603 25.825 26.269 26.658" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Aumento de la ACTH plasmática en personas con neoplasias hipoﬁ sarias.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.005 2.449 2.893 3.171 3.615 3.893 4.115 4.559 4.781 5.17 5.614 6.058 6.336 6.78 7.058 7.336 7.78 8.224 8.668 8.89 9.112 9.779 10.223 10.667 10.889 11.333 11.777 12.055 12.499 12.721 12.943 13.387 13.609 14.053 14.497 15.164 15.386 15.83 16.052 16.441 16.719 16.997 17.441 17.83 18.052 18.496 18.94 19.162 19.606 20.05 20.272 20.661 21.105 21.549 21.827 22.105 22.549 22.938 23.216 23.66" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Angiografía suprarrenal mediante la administración de contraste.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 1.949 2.393 2.837 3.115 3.559 3.837 4.059 4.503 4.892 5.114 5.558 6.002 6.224 6.446 6.835 7.113 7.557 8.001 8.445 8.889 9.111 9.555 9.999 10.277 10.721 10.943 11.387 11.831 12.109 12.553 12.942 13.22 13.664 13.942 14.164 14.608 14.886 15.33 15.719 15.941 16.385 16.829 17.051 17.495 17.939 18.161 18.383 18.827 19.049 19.438 19.66 19.882 20.104 20.548 20.77 21.048 21.492 21.77 22.159 22.603 22.825 23.269 23.713 23.991 24.213 24.657 25.101 25.545 25.767 26.211 26.655 27.099 27.543 27.765 28.209 28.598 28.82 29.264 29.486 29.93 30.152 30.596 31.04 31.262 31.484 31.873 32.317 32.595 32.817 33.261" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Radiografías del cráneo para detectar erosión de la silla turca por una neoplasia hipoﬁ saria.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.672 2.116 2.56 3.004 3.448 3.837 4.059 4.503 4.725 5.169 5.613 6.002 6.224 6.668 7.112 7.39 7.612 8.279 8.723 9.167 9.611 10.055 10.333 10.555 10.944 11.388 11.61 12.054 12.498 12.72 12.942 13.386 13.608 14.052 14.274 14.718 15.162 15.384 15.606 15.995 16.217 16.606 16.828 17.217 17.439 17.883 18.327 18.549 18.771 19.215 19.604 19.826 20.27 20.492 20.936 21.38 21.824 22.268 22.49 22.934 23.323 23.545 23.934 24.378 24.822 25.1 25.544 25.822 26.1 26.544 26.988 27.432 27.654 28.098 28.487 28.709 29.153 29.597 29.875 30.319 30.541 30.763 31.207 31.596 32.04 32.262 32.484 32.817 33.261 33.539 33.761 34.205 34.427 34.649 34.927 35.371 36.038 36.482 36.69" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Resonancia nuclear magnética de la hipóﬁ sis y de las glándulas suprarrenales para localizar el tumor.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 569.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.833 1.333 1.833 2.111 2.611 3.111 3.555 3.777 4.055 4.555 4.888 5.388 5.888 6.388 6.888 7.166 7.444 7.944 8.444 8.888" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Medidas terapéuticas </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 547.8375) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 547.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 1.005 1.283 1.727 2.005 2.394 2.838 3.282 3.671 3.893 4.337 4.781 5.225 5.614 5.836 6.28 6.724 6.946 7.224 7.668 7.946 8.613 9.057 9.446 9.89 10.112 10.556 11 11.222 11.611 12.055 12.444" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Intervenciones no farmacológicas:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 536.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.167 2.445 2.889 3.111 3.555 3.777 4.221 4.665 5.054 5.498 5.72 6.164 6.442 6.664 7.053 7.497 7.719 7.941 8.385 8.607 9.051 9.495 9.884 10.328 10.772 10.994 11.383 11.827 12.049 12.438 12.66 13.104 13.326 13.548 14.215 14.659 15.103 15.381 15.825 16.214 16.436 16.714 16.936 17.325 17.769 18.158 18.38 18.824 19.268 19.49 19.934 20.378 20.656 21.1 21.489 21.711 22.155" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Dieta hipocalórica, hiposódica y alimentos ricos en potasio.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 514.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 514.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.5609 1.0049 1.2829 1.7269 2.0049 2.3939 2.8379 3.2819 3.6709 3.8929 4.3369 4.7809 5.2249 5.6139 5.8358 6.1138 6.5578 6.8358 7.5028 7.9468 8.3358 8.7798 9.0018 9.4458 9.8898 10.1118 10.5008 10.9448 11.3338" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Intervenciones farmacológicas:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 503.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.945 2.223 2.445 2.889 3.111 3.555 3.999 4.277 4.555 4.999 5.443 5.832 6.054 6.443 6.887 7.276 7.498 7.72 8.164 8.386 8.83 9.108 9.552 9.83 10.052 10.441 10.885 11.274 11.496 11.718 12.107 12.551 12.995 13.217 13.661 14.328 14.772 15.216 15.494 15.938 16.327 16.549 16.993 17.437 17.659 18.103 18.547 18.825 19.269 19.658 19.88 20.324 20.546 20.99 21.212 21.434 21.878 22.267 22.711 22.933 23.155 23.599 24.043" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Antihipertensivos, diuréticos, suplementos de potasio e insulina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 492.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.9449 2.2229 2.4449 2.8889 3.3329 3.6109 4.2779 4.7219 5.1659 5.6099 5.8319 6.2759 6.6649 6.8868 7.2758 7.4978 7.7758 8.2198 8.4978 8.9418 9.3308 9.5528 9.9418 10.3858 10.7748" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Antihormonales citotóxicos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 481.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.611 2.055 2.277 2.721 2.943 3.387 3.831 4.109 4.553 4.942 5.164 5.608 6.052 6.274 6.718 7.162 7.495 7.717 8.384 8.828 9.217 9.439 9.828 10.272 10.716 10.994 11.438 11.716 11.994 12.438 12.882 13.326 13.548 13.992 14.381 14.603 14.825 15.492 15.936 16.214 16.436 16.714 17.158 17.602 18.046 18.49 18.934 19.156 19.378 19.822 20.489 20.711 21.155 21.599 22.043 22.265 22.709 22.987 23.431 23.709 23.931 24.598 24.82 25.264 25.708" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Inhibidores de enzimas suprarrenales: metirapona, aminoglutetimida.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 470.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2.056 2.723 3.167 3.556 4 4.389 4.611 5 5.444 5.888 6.166 6.444 6.888 7.11 7.554 7.943 8.165 8.609 9.053 9.275 9.775 10.219 10.608 11.052 11.274 11.718 12.162 12.384 12.828 13.05 13.494 13.938 14.16 14.382 14.771 15.215 15.493 15.715 16.159 16.381 16.603 17.047 17.325 17.769 18.436 18.88 19.269 19.547 19.769 20.213 20.491 20.713 21.157 21.601 21.823 22.045 22.489 22.933 23.211 23.655 24.099 24.543 24.987 25.209 25.598 25.876 26.32 26.709 26.931 27.375 27.819 28.041 28.263 28.707 28.929 29.318 29.762 30.04 30.484 30.762 31.206 31.65 31.872 32.316 32.76 32.982 33.426 33.87 34.314 34.536 34.758 35.202 35.646 35.868 36.312 36.756 36.978 37.2 37.644 37.866 38.255 38.699 39.088 39.366 39.81 40.199 40.421 40.865 41.309 41.531 41.975 42.419 42.641 43.197 43.697 44.141 44.697" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Fármacos centrales de Cushing hipoﬁ sario: bromocriptina, antagonistas de la serotonina que inhibe la secreción de ACTH.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 459.839) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.667 2.111 2.555 2.999 3.443 3.887 4.331 4.775 5.053 5.497 5.886 6.108 6.552 6.996 7.218 7.496 7.94 8.329 8.773 9.217 9.495 9.939 10.217 10.661 11.05 11.272 11.716 12.16 12.382 12.771 13.215 13.493 13.771 13.993 14.382 14.826 15.215 15.493 15.937 16.215 16.659 16.881 17.325 17.769 18.158 18.38 18.602 19.269 19.491 19.769 20.213 20.657 20.935 21.157 21.546 21.824 22.268 22.712 23.156" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Bloqueadores de receptores de corticosteroides: mifepristona.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 448.8392) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 1.945 2.389 2.833 3.111 3.555 3.777 4.221 4.61 5.054 5.332 5.61 5.832 6.221 6.665 6.887 7.331 7.775 8.164 8.386 8.775 8.997 9.441 9.663 10.107 10.496 10.94 11.329 11.773 12.051 12.329 12.551 12.94 13.384 13.606 14.05 14.494 14.883" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Mineralocorticoides y glucocorticoides.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 426.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 426.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.8949 1.3389 1.5609 1.8389 2.2829 2.5609 3.0049 3.2269 3.6159 4.0599 4.4489" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Quirúrgicos:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 415.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.611 3.055 3.333 3.611 4.055 4.499 4.943 5.165 5.609 5.998 6.276 6.72 7.387 7.609 8.053 8.275 8.719 8.941 9.163 9.607 9.885 10.329 10.607 11.051 11.273 11.495 11.939 12.161 12.605 13.049 13.271 13.493 13.937 14.215 14.659 14.937 15.381 15.603" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Suprarrenalectomía bilateral o unilateral.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 404.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 1.945 2.334 2.612 3.056 3.445 3.667 3.945 4.389 4.833 5.055 5.499 5.721 5.999 6.277 6.721 7.165 7.554 7.998 8.387 8.665 9.109 9.553 9.997 10.219 10.663 11.107 11.329 11.551 11.995 12.439 12.661 12.883 13.327 13.549 13.993 14.215 14.659 15.103 15.325 15.547 15.936 16.158 16.547" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Microcirugía transesfenoidal de la hipóﬁ sis.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 393.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.7229 2.1669 2.6109 2.8329 3.0548 3.4438 3.8878 4.2768 4.5548 4.9988 5.6658 5.8878 6.3318" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Hipoﬁ sectomía.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.5609 0.8389 1.1169 1.5609 2.0049 2.2269 2.6709 3.0599 3.2819 3.7259 4.1699" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Irradiación:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 360.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.167 1.445 1.723 2.167 2.611 2.833 3.277 3.666 3.888 4.332 4.776 4.998 5.442 5.886 6.108 6.33 6.774 6.996 7.44 7.662 8.106 8.55 8.772 8.994 9.383 9.605 9.994 10.216 10.605 11.049 11.493 11.715 11.937 12.604 13.048 13.27 13.714 14.158 14.436 14.88 15.269 15.491 15.935 16.379 16.601 17.045 17.489 17.711 18.1 18.544 18.822 19.044 19.266 19.488 19.932 20.321 20.543 20.987 21.431 21.653 21.875 22.153 22.431 22.653 23.097 23.319 23.763 24.207" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Irradiación de la hipóﬁ sis con implantación de varillas de itrio 90.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 338.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1 1.611 2.167 2.556 3.112 3.39 4.001 4.612 5.112 5.445 6.001 6.39 7.001 7.612 7.89 8.39 9.334" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Hiperaldosteronismo</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.055 1.277 1.721 1.943 2.387 2.665 3.109 3.553 3.997 4.386 4.775 4.997 5.441 5.885 6.107 6.551 6.94 7.329 7.773 8.162 8.384 8.773 9.217 9.439 9.883 10.327 10.549 11.216 11.438 11.882 12.326 12.604 13.048 13.27 13.714 14.103 14.547 14.825 15.103 15.325 15.714 16.158 16.38 16.824 17.268 17.657 17.879 18.101 18.545 18.767 19.211 19.655 20.044 20.322 20.766 21.044 21.488 21.932 22.376 22.598 22.82 23.264 23.708 23.986 24.208 24.43 24.874 25.096 25.485 25.929 26.207 26.485 26.929 27.262 27.706 27.928 28.317 28.761 29.205 29.483 29.927 30.205 30.483 30.927 31.371 31.815 32.037" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Es la producción excesiva de mineralocorticoides (aldosterona) por la corteza suprarrenal.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 294.7931) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.611 0.889 1.389 1.889 2.333 2.611 3.111 3.444 3.944 4.444 4.722 5.166 5.888 6.388 6.61 7.11 7.443 7.721 8.443 8.943 9.276 9.554" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Aldosteronismo primario</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 272.838499) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.949 2.338 2.56 3.004 3.448 3.892 4.336 4.78 5.002 5.391 5.835 6.279 6.501 6.945 7.389 7.833 8.055 8.499 8.721 8.999 9.443 9.721 10.165 10.554 10.776 11.22 11.664 11.886 12.33 12.608 12.83 13.497 13.941 14.219 14.441 14.885 15.107 15.551 15.995 16.217 16.439 16.883 17.105 17.549 17.771 18.215 18.659 19.103 19.547 19.769 20.213 20.435" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Relacionado con una alteración primaria de la glándula. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 261.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 261.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 1.117 1.561 1.95 2.172 2.616 3.06 3.504 3.726 4.004 4.448 4.892 5.114 5.336 5.78 6.224 6.446 7.113 7.557 7.779 8.223 8.501 8.945 9.334 9.556 10 10.444 10.888 11.11 11.554 11.998 12.22 12.664 13.108 13.775 14.219 14.497 14.941 15.33 15.552 15.996 16.44 16.662 17.106 17.55 17.994 18.216 18.66 18.938 19.382 19.826 20.27 20.548 20.937 21.159 21.603 22.047 22.269 22.713 23.157 23.379 23.823 24.045 24.489 24.711 25.1 25.322 25.989 26.433 26.822 27.044 27.433 27.877 28.544 28.988 29.432 29.654 30.098 30.542 30.764 31.042 31.486 31.819 32.263 32.485 32.929 33.373 33.817 34.095 34.539" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Más habitual en mujeres que en hombres en una proporción de 2:1 y más común en raza negra.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 250.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 250.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.728 1.95 2.339 2.783 3.061 3.283 3.727 4.116 4.338 4.616 5.06 5.338 6.005 6.449 6.838 7.06 7.504 7.948 8.17 8.614 8.836 9.28 9.724 10.002 10.446 10.668 11.112 11.556 11.945 12.223 12.667 12.945 13.389 13.833 14.055 14.444 15.111 15.555 15.777 16.221 16.499 16.721 17.388 17.832 18.11 18.332 18.776" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Hay varias formas de hiperaldosteronismo primario:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 239.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.945 2.389 2.833 3.277 3.944 4.388 4.61 4.999 5.443 5.721 5.999 6.221 6.61 7.054 7.443 7.887 8.331 8.609 9.053 9.331 9.609 10.053 10.497 10.941 11.163 11.385 11.774 12.218 12.44 12.662 12.94 13.384 13.662 13.884 14.328 14.55 14.994 15.216 15.605 15.827 16.271 16.715 16.993 17.437 18.104 18.548 18.77 19.214 19.658 19.88 20.38 20.824 21.268 21.712 21.934 22.156 22.6 22.989 23.211 23.433 23.877 24.099 24.377 24.821 25.099 25.766 26.21 26.432 27.099 27.543 27.932 28.154 28.543 28.987 29.654 30.098 30.542 30.764 30.986 31.43 31.874 32.152 32.596 33.04 33.818 34.04" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Adenoma corticosuprarrenal solitario o síndrome de Conn: es la forma más común (60-70%).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 228.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.167 2.611 2.889 3.333 3.555 3.999 4.388 4.61 5.054 5.276 5.665 6.109 6.387 6.665 6.887 7.276 7.72 8.109 8.553 8.997 9.275 9.719 9.997 10.275 10.719 11.163 11.607 11.829 12.051 12.495 12.717 12.939 13.383 13.661 14.105 14.383 14.827 15.049 15.271 15.715 15.937 16.381 16.603 17.047 17.491 17.769 18.213 18.435 18.879 19.323 19.712 19.99 20.434 20.712 21.156 21.6 21.822 22.211 22.878 23.322 23.544 23.766 24.21 24.432 24.876 25.32 25.764 26.042 26.264 26.653 27.097 27.319 27.541 27.985 28.429 28.707 29.151 29.595 30.373 30.595 31.039 31.483 31.705 31.927 32.371 32.76 32.982 33.371 33.815 34.204 34.648 35.037" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Hiperplasia corticosuprarrenal bilateral o hiperaldosteronismo idiopático: 15-30% de los casos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 217.8387) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.167 2.556 2.778 3.222 3.666 4.333 4.777 4.999 5.388 5.832 6.276 6.554 6.998 7.276 7.554 7.998 8.442 8.886 9.108 9.33 9.552 9.996 10.385 10.607 11.051 11.44 11.829 12.273 12.717 13.106 13.328 13.772 14.216 14.66 14.882" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Carcinoma suprarrenal: es excepcional.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.449 1.893 2.115 2.337 2.781 3.003 3.447 3.891 4.28 4.558 5.002 5.28 5.724 6.168 6.39 6.779 7.446 7.89 8.112 8.556 8.834 9.056 9.723 10.167 10.445 10.667 11.111 11.333 11.777 11.999 12.221 12.665 13.054 13.443 13.887 14.276 14.72 14.942 15.386 15.83 16.052 16.496 16.718 17.162 17.606 17.995 18.273 18.717 18.995 19.439 19.883 20.327 20.549 20.993 21.271 21.715 22.104 22.548 22.937 23.381" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> En el aldosteronismo primario el exceso de aldosterona provoca:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 184.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.945 2.612 3.056 3.5 3.778 4.222 4.444 4.888 5.332 5.554 5.776 6.22 6.442 6.72 7.164 7.608 8.052 8.441 8.885 9.163 9.552 9.774 10.218 10.662 10.884 11.328 11.772 11.994 12.383 12.827 13.271 13.493 13.937 14.159 14.603 15.047 15.325 15.547 15.825 16.269 16.936 17.38 17.602 18.046 18.435 18.657 18.935 19.379 19.823 20.267 20.489 20.933 21.322 21.544 21.988 22.21 22.599 22.877 23.321 23.543 23.987 24.376" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Aumento de la reabsorción de sodio por túmulos renales distales.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 173.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 2.167 2.556 3 3.278 3.5 3.778 4.222 4.666 5.11 5.499 5.943 6.221 6.61 6.832 7.276 7.72 7.942 8.386 8.83 9.052 9.496 9.94 10.384 10.828 11.05 11.717 12.161 12.605 12.883 13.327 13.771 13.993 14.437 14.881 15.325 15.769 15.991 16.213 16.657 16.879 17.268 17.712 18.156 18.545 18.989 19.433 19.711 19.989 20.433 20.822 21.044 21.488 21.932 22.154 22.598 23.042 23.264 23.653 24.097 24.541 24.763 25.207 25.429 25.873 26.317 26.595 27.262 27.706 27.928" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Mayor reabsorción de agua manteniendo la concentración de sodio normal.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 162.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.7229 2.1669 2.6109 2.8889 3.1669 3.6109 4.0549 4.4439 4.6659 5.1099 5.5539" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Hipertensión.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 151.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.167 2.611 3.055 3.499 3.777 4.221 4.61 5.054 5.721 5.943 6.387 6.609 7.053 7.497 7.941 8.163 8.607 9.051 9.273 9.717 9.939 10.383 10.827 11.271 11.493 11.882 12.326 12.548 12.992 13.214 13.658 13.936 14.38 14.824 15.046 15.49 15.934 16.212 16.656 17.045 17.267 17.711 17.933 18.377 18.821 19.099 19.321 19.765 19.987 20.209 20.487 20.931 21.375 21.819 22.041 22.485 22.707 22.985 23.429 23.873 24.317 24.539 24.761 25.205 25.427 25.816 26.094 26.538 26.76" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Hipopotasemia debido a que se pierde potasio por el túbulo renal distal.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 129.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.611 0.889 1.389 1.889 2.333 2.611 3.111 3.444 3.944 4.444 4.722 5.166 5.888 6.388 6.61 7.054 7.554 8.054 8.554 9.054 9.554 10.054 10.387 10.665" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Aldosteronismo secundario</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 107.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.388 1.777 2.221 2.61 3.054 3.498 3.942 4.331 4.553 4.997 5.219 5.663 6.107 6.329 6.773 6.995 7.384 7.828 8.106 8.495 8.939 9.328 9.55 9.994 10.272 10.716 11.105 11.549 11.938 12.382 12.771 12.993 13.437 13.826 14.104 14.382 14.826 15.215 15.659 16.103 16.381 16.825 17.103 17.381 17.825 18.269 18.713 18.935 19.379 19.768 19.99 20.434 20.878 21.322 21.544 21.988 22.377 22.655 22.877 23.266 23.71 24.154 24.376 24.82 25.042 25.264 25.653 25.875 26.264 26.542 26.986 27.653 28.097 28.319 28.597 29.041 29.485 29.707 30.151 30.595 30.873 31.317 31.761 32.205 32.427 32.871 33.149 33.593 34.037 34.426 34.648 35.092 35.536 35.758" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Consecuencia de diversos procesos extrasuprarrenales que activan el sistema renina-angiotensina: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.505 1.949 2.227 2.894 3.338 3.782 4.226 4.67 5.114 5.503 5.725 6.169 6.613 7.057 7.279 7.668 8.112 8.39 8.779 9.223 9.667 9.889 10.278 10.722 11.166 11.388 11.832 12.276 12.72 13.387 13.831 14.22" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Enfermedades que cursan con edemas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.505 1.949 2.227 2.894 3.338 3.782 4.226 4.67 5.114 5.503 5.725 6.169 6.613 7.057 7.279 7.668 8.112 8.39 8.779 9.223 9.667 9.889 10.278 10.722 11.166 11.388 11.944 12.338 12.894 13.116 13.394 13.838 14.282 14.504 14.948 15.392 15.614 16.058 16.502 16.946 17.39 17.834 18.278 18.5 18.944 19.388 19.666 20.11" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Enfermedades que cursan con HTA renina dependiente.</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>